Compugen Ltd (CGEN)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

26 HAROKMIM STREET HOLON, ISRAEL 5885849

Develops computer hardware and software applications to enable scientists to enhance their research efforts in drug discovery, therapeutics and diagnostics. The company's Keddem Bioscience Ltd. is focused on small molecule drug discovery.

Data as of 2020-05-30
Market Cap1.22 Billion Shares Outstanding79.275 Million Avg 30-day Volume1.628 Million
P/E Ratio Dividend Yield EPS-0.54
Price/Sales Price cash flow ratio Price free cash flow ratio-22.1
Book Value1.44 Price to Tangible Book8.6 Alpha0.01
Short Interest Ratio % Short Interest to Float R-squared0.290924
BETA2.83208 52-week High/Low16.31 / 2.73 Stddev0.224463
View SEC Filings from CGEN instead.

Funds Holding CGEN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CGEN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

Elevate your investments